Race Oncology Ltd. (AU:RAC) has released an update.
Race Oncology Ltd has announced an application for the quotation of new securities on the Australian Securities Exchange (ASX) under the code RAC. The request, dated September 13, 2024, includes a total of 12,825 ordinary fully paid shares. This move indicates the company’s efforts to expand its financial horizons in the biotechnology sector.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.
